PMMA stands for: Poly-Microbial Molecular Assay. It is a new, revolutionary genetic innovation in the management of UTI’s. PMMA is capable of simultaneous identification of 27 different uropathogens and 8 different antibiotic resistant genes. IMD™ favors this methodology due to it’s more accurate identification of infection at a rate nearly 6 times greater than traditional culture and is proud to offer next day turnaround time on all specimens utilizing this panel.